From the article by Lena H. Sun:
The Cleveland model is a combination of royalties from licenses of technologies to established companies and the sale of shares in spin-off companies. Royalties from licensing generate about $10 million yearly, but overall revenue is increasing significantly, said Chris Coburn, executive director of Cleveland Clinic Innovations. Last week, Boston Scientific paid $78 million for a Cleveland Clinic spin-off that is developing a system that uses deep-brain stimulation to treat traumatic brain injury.
No comments:
Post a Comment